MedTrace Logo

Does Icodextrin Reduce the Risk of Small Bowel Obstruction?

NCT02318888 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1808

Last updated 2020-03-31

No results posted yet for this study

Summary

The study aims at investigating if icodextrin 4% instilled in abdominal cavity during surgery can reduce the risk of surgery and hospitalisation for small bowel obstruction in patients with colorectal cancer. Follow-up data is collected from the Swedish national colorectal cancer registry.Patients are followed for 5 years postoperatively.The study is a randomized Swedish multicenter study and planned to include 1,800 patients. A safety control is planned after 300 included patients.

Conditions

  • Surgical Adhesions

Interventions

PROCEDURE

Surgery

DRUG

Icodextrin

Sponsors & Collaborators

  • Uppsala University

    lead OTHER

Principal Investigators

  • Urban Karlbom, PhD · University Hospital, Uppsala

  • Lars Påhlman, Professor · University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02318888 on ClinicalTrials.gov